These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 6395814

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
    Lell B, Lehman LG, Schmidt-Ott JR, Sturchler D, Handschin J, Kremsner PG.
    Am J Trop Med Hyg; 1998 May; 58(5):619-24. PubMed ID: 9598451
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T, Bunnag D, Vanijanond S, Charoenlarp P, Suntharasmai P, Chitamas S, Sheth UK, Wernsdorfer WH.
    Bull World Health Organ; 1987 May; 65(3):363-7. PubMed ID: 3311439
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM, Simooya OO, Sheth UK, Wernsdorfer WH, Njelesani EK.
    Bull World Health Organ; 1985 May; 63(2):339-43. PubMed ID: 3893778
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G.
    Trans R Soc Trop Med Hyg; 1988 May; 82(4):524-9. PubMed ID: 2908258
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.
    Nosten F, Imvithaya S, Vincenti M, Delmas G, Lebihan G, Hausler B, White N.
    Bull World Health Organ; 1987 May; 65(6):891-6. PubMed ID: 3325187
    [Abstract] [Full Text] [Related]

  • 38. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
    Arnold K.
    Lancet; 1985 Mar 23; 1(8430):704. PubMed ID: 2858655
    [No Abstract] [Full Text] [Related]

  • 39. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate?
    Peters W.
    Ann Trop Med Parasitol; 1999 Sep 23; 93(6):569-87. PubMed ID: 10707103
    [Abstract] [Full Text] [Related]

  • 40. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM.
    Bull World Health Organ; 1983 Sep 23; 61(5):815-20. PubMed ID: 6360401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.